Michael Koeris
Founder at Corvium, Inc.
Profile
Michael Koeris is the founder of Corvium, Inc. (founded in 2009) and Vulcan Biologics, Inc. (founded in 2019), where he holds the titles of Director and President, Secretary & Treasurer respectively.
Dr. Koeris is also the founder of GDMC Pte Ltd.
Currently, Dr. Koeris is a Director at Xeno Biosciences, Inc. In the past, he worked as a Principal at KPMG Consulting, Inc. and McKinsey GmbH & Co. KG.
Dr. Koeris obtained a doctorate degree from Boston University and completed undergraduate and graduate studies at Freie Universität Berlin.
Michael Koeris active positions
| Companies | Position | Start |
|---|---|---|
Corvium, Inc.
 Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Founder | 2009-02-28 |
Xeno Biosciences, Inc.
 Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Director/Board Member | - |
Vulcan Biologics, Inc.
 Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Founder | 2019-10-28 |
Former positions of Michael Koeris
| Companies | Position | End |
|---|---|---|
McKinsey GmbH & Co. KG
 McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Corporate Officer/Principal | - |
| KPMG Consulting, Inc. | Corporate Officer/Principal | - |
Training of Michael Koeris
| Boston University | Doctorate Degree |
| Freie Universität Berlin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
| KPMG Consulting, Inc. | Commercial Services |
Corvium, Inc.
Corvium, Inc. Packaged SoftwareTechnology Services Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA. | Technology Services |
Xeno Biosciences, Inc.
Xeno Biosciences, Inc. BiotechnologyHealth Technology Xeno Biosciences, Inc. operates as a biopharmaceutical company. It offers XEN-101, an oral formulation that shifts the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery. The company was founded by Hasan Celiker and is headquartered in Somerville, MA. | Health Technology |
Vulcan Biologics, Inc.
Vulcan Biologics, Inc. BiotechnologyHealth Technology Vulcan Biologics, Inc. is a company that focuses on next-generation microbiome modulation. Vulcan Biologics is based in Irvine, CA and was founded by Michael Koeris, who has been the CEO since incorporation. The company aims to precisely and stably modulate any arbitrary microbiome, which is key to any commercial and clinical success. The company is building a broad platform to modulate any microbiome, focusing on integrative and next-generation approaches to achieve predictable stability in the engineered microbiomes. | Health Technology |
McKinsey GmbH & Co. KG
McKinsey GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services McKinsey GmbH & Co. KG provides business consulting services. The company was founded on October 18, 2011 and is headquartered in Düsseldorf, Germany. | Commercial Services |
- Stock Market
- Insiders
- Michael Koeris
